Survival Analysis

"Survival Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.

Descriptor ID	D016019
MeSH Number(s)	E05.318.740.998 N05.715.360.750.795 N06.850.520.830.998
Concept/Terms	Survival Analysis Survival Analysis Analysis, Survival Analyses, Survival Survival Analyses

Below are MeSH descriptors whose meaning is more general than "Survival Analysis".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Statistics as Topic [E05.318.740]
Survival Analysis [E05.318.740.998]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Statistics as Topic [N05.715.360.750]
Survival Analysis [N05.715.360.750.795]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Statistics as Topic [N06.850.520.830]
Survival Analysis [N06.850.520.830.998]

Below are MeSH descriptors whose meaning is more specific than "Survival Analysis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Survival Analysis" by people in this website by year, and whether "Survival Analysis" was a major or minor topic of these publications.

Bar chart showing 205 publications over 27 distinct years, with a maximum of 20 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1994	0	3	3
1996	0	4	4
1998	0	3	3
1999	0	1	1
2000	0	3	3
2001	0	2	2
2002	0	8	8
2003	0	6	6
2004	0	6	6
2005	1	5	6
2006	0	7	7
2007	0	15	15
2008	0	7	7
2009	0	4	4
2010	0	16	16
2011	1	12	13
2012	0	13	13
2013	0	7	7
2014	0	9	9
2015	1	19	20
2016	0	16	16
2017	0	11	11
2018	0	4	4
2019	0	11	11
2020	0	7	7
2021	0	2	2

Below are the most recent publications written about "Survival Analysis" by people in Profiles.

Bui Q, Ngo TNM, Mazur J, Pham V, Palmer C, Truong BQ, Chung ES, Vuong HG, Truong VT. Long-term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population. Cancer Med. 2021 12; 10(24):8838-8845.

View in: PubMed
Tannir NM, Papadopoulos KP, Wong DJ, Aljumaily R, Hung A, Afable M, Kim JS, Ferry D, Drakaki A, Bendell J, Naing A. Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study. Int J Cancer. 2021 07 15; 149(2):403-408.

View in: PubMed
Buechel ME, Enserro D, Burger RA, Brady MF, Wade K, Secord AA, Nixon AB, Mirniaharikandehei S, Liu H, Zheng B, O'Malley DM, Gray H, Tewari KS, Mannel RS, Birrer MJ, Moore KN. Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC). Gynecol Oncol. 2021 05; 161(2):382-388.

View in: PubMed
Zhou Z, Zhang J, Xu C, Yang J, Zhang Y, Liu M, Shi X, Li X, Zhan H, Chen W, McNally LR, Fung KM, Luo W, Houchen CW, He Y, Zhang C, Li M. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.

View in: PubMed
Shankar B, Zhang J, Naqash AR, Forde PM, Feliciano JL, Marrone KA, Ettinger DS, Hann CL, Brahmer JR, Ricciuti B, Owen D, Toi Y, Walker P, Otterson GA, Patel SH, Sugawara S, Naidoo J. Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer. JAMA Oncol. 2020 12 01; 6(12):1952-1956.

View in: PubMed
Oh S, Song H, Freeman WM, Shin S, Janknecht R. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer. Int J Oncol. 2020 12; 57(6):1319-1332.

View in: PubMed
Vuong HG, Nguyen TQ, Ngo TNM, Nguyen HC, Fung KM, Dunn IF. The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis. BMC Cancer. 2020 Sep 21; 20(1):897.

View in: PubMed
Sung AD, Yen RC, Jiao Y, Bernanke A, Lewis DA, Miller SE, Li Z, Ross JR, Artica A, Piryani S, Zhou D, Liu Y, Vo-Dinh T, Hoffman M, Ortel TL, Chao NJ, Chen BJ. Fibrinogen-Coated Albumin Nanospheres Prevent Thrombocytopenia-Related Bleeding. Radiat Res. 2020 08 01; 194(2):162-172.

View in: PubMed
Houchen CW, Li M. A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma. BMC Med. 2020 06 29; 18(1):155.

View in: PubMed
Dang TT, Morales JC. Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress. Int J Mol Sci. 2020 Jun 15; 21(12).

View in: PubMed

People

Explore

Similar Concepts

Top Journals